IBDEI1FJ ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24297,1,3,0)
 ;;=3^Cannabis Induced Psychotic Disorder w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,24297,1,4,0)
 ;;=4^F12.959
 ;;^UTILITY(U,$J,358.3,24297,2)
 ;;=^5003185
 ;;^UTILITY(U,$J,358.3,24298,0)
 ;;=F12.988^^90^1063^5
 ;;^UTILITY(U,$J,358.3,24298,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24298,1,3,0)
 ;;=3^Cannabis Induced Sleep Disorder w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,24298,1,4,0)
 ;;=4^F12.988
 ;;^UTILITY(U,$J,358.3,24298,2)
 ;;=^5003187
 ;;^UTILITY(U,$J,358.3,24299,0)
 ;;=F12.929^^90^1063^13
 ;;^UTILITY(U,$J,358.3,24299,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24299,1,3,0)
 ;;=3^Cannabis Intoxication w/o Perceptual Disturbances w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,24299,1,4,0)
 ;;=4^F12.929
 ;;^UTILITY(U,$J,358.3,24299,2)
 ;;=^5003182
 ;;^UTILITY(U,$J,358.3,24300,0)
 ;;=F12.99^^90^1063^15
 ;;^UTILITY(U,$J,358.3,24300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24300,1,3,0)
 ;;=3^Cannabis Related Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,24300,1,4,0)
 ;;=4^F12.99
 ;;^UTILITY(U,$J,358.3,24300,2)
 ;;=^5003188
 ;;^UTILITY(U,$J,358.3,24301,0)
 ;;=F16.10^^90^1064^17
 ;;^UTILITY(U,$J,358.3,24301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24301,1,3,0)
 ;;=3^Phencyclidine Use Disorder,Mild
 ;;^UTILITY(U,$J,358.3,24301,1,4,0)
 ;;=4^F16.10
 ;;^UTILITY(U,$J,358.3,24301,2)
 ;;=^5003323
 ;;^UTILITY(U,$J,358.3,24302,0)
 ;;=F16.20^^90^1064^18
 ;;^UTILITY(U,$J,358.3,24302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24302,1,3,0)
 ;;=3^Phencyclidine Use Disorder,Moderate-Severe
 ;;^UTILITY(U,$J,358.3,24302,1,4,0)
 ;;=4^F16.20
 ;;^UTILITY(U,$J,358.3,24302,2)
 ;;=^5003336
 ;;^UTILITY(U,$J,358.3,24303,0)
 ;;=F16.21^^90^1064^19
 ;;^UTILITY(U,$J,358.3,24303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24303,1,3,0)
 ;;=3^Phencyclidine Use Disorder,Moderate-Severe,In Remission
 ;;^UTILITY(U,$J,358.3,24303,1,4,0)
 ;;=4^F16.21
 ;;^UTILITY(U,$J,358.3,24303,2)
 ;;=^5003337
 ;;^UTILITY(U,$J,358.3,24304,0)
 ;;=F16.983^^90^1064^16
 ;;^UTILITY(U,$J,358.3,24304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24304,1,3,0)
 ;;=3^Hallucinogen Persisting Perception Disorder
 ;;^UTILITY(U,$J,358.3,24304,1,4,0)
 ;;=4^F16.983
 ;;^UTILITY(U,$J,358.3,24304,2)
 ;;=^5003358
 ;;^UTILITY(U,$J,358.3,24305,0)
 ;;=F16.121^^90^1064^10
 ;;^UTILITY(U,$J,358.3,24305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24305,1,3,0)
 ;;=3^Hallucinogen Intoxication Delirium w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,24305,1,4,0)
 ;;=4^F16.121
 ;;^UTILITY(U,$J,358.3,24305,2)
 ;;=^5003325
 ;;^UTILITY(U,$J,358.3,24306,0)
 ;;=F16.221^^90^1064^11
 ;;^UTILITY(U,$J,358.3,24306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24306,1,3,0)
 ;;=3^Hallucinogen Intoxication Delirium w/ Mod/Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,24306,1,4,0)
 ;;=4^F16.221
 ;;^UTILITY(U,$J,358.3,24306,2)
 ;;=^5003339
 ;;^UTILITY(U,$J,358.3,24307,0)
 ;;=F16.921^^90^1064^12
 ;;^UTILITY(U,$J,358.3,24307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24307,1,3,0)
 ;;=3^Hallucinogen Intoxication Delirium w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,24307,1,4,0)
 ;;=4^F16.921
 ;;^UTILITY(U,$J,358.3,24307,2)
 ;;=^5003351
 ;;^UTILITY(U,$J,358.3,24308,0)
 ;;=F16.129^^90^1064^13
 ;;^UTILITY(U,$J,358.3,24308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24308,1,3,0)
 ;;=3^Hallucinogen Intoxication w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,24308,1,4,0)
 ;;=4^F16.129
 ;;^UTILITY(U,$J,358.3,24308,2)
 ;;=^5003327
 ;;^UTILITY(U,$J,358.3,24309,0)
 ;;=F16.229^^90^1064^14
 ;;^UTILITY(U,$J,358.3,24309,1,0)
 ;;=^358.31IA^4^2
